BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7776446)

  • 1. A new protocol for the followup of renal cell carcinoma based on pathological stage.
    Sandock DS; Seftel AD; Resnick MI
    J Urol; 1995 Jul; 154(1):28-31. PubMed ID: 7776446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA; Slaton JW; Swanson DA; Dinney CP
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local recurrence and metastatic dissemination of renal cell carcinoma: clinical and imaging characteristics].
    Mignon F; Mesurolle B
    J Radiol; 2003 Mar; 84(3):275-84. PubMed ID: 12736586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
    Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
    J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
    Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
    J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.
    Chevinsky M; Imnadze M; Sankin A; Winer A; Mano R; Jakubowski C; Mashni J; Sjoberg DD; Chen YB; Tickoo SK; Reuter VE; Hakimi AA; Russo P
    J Urol; 2015 Aug; 194(2):310-5. PubMed ID: 25676433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
    Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of pancreatic metastasis from renal cell carcinoma].
    Chi TY; Sang XT; Mao YL; Yang ZY; Lu X; Zhong SX; Huang JF
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):793-6. PubMed ID: 19173818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role radiography in assessing the stage of renal cancer].
    Gorelov AI; Tiushin LA; Bogdanova EO; Rosenhaus EV; Shelkoplias EN
    Vopr Onkol; 1998; 44(6):683-5. PubMed ID: 10087964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery for stage IV renal cell carcinoma.
    Bennett RT; Lerner SE; Taub HC; Dutcher JP; Fleischmann J
    J Urol; 1995 Jul; 154(1):32-4. PubMed ID: 7776449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
    Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
    J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.
    Frees SK; Kamal MM; Nestler S; Levien PM; Bidnur S; Brenner W; Thomas C; Jaeger W; Thüroff JW; Roos FC
    Int J Urol; 2019 Mar; 26(3):385-390. PubMed ID: 30588677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma: analysis of postoperative recurrence patterns.
    Chae EJ; Kim JK; Kim SH; Bae SJ; Cho KS
    Radiology; 2005 Jan; 234(1):189-96. PubMed ID: 15537838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of pulmonary solitary metastasis of renal cell carcinoma nine years after radical nephrectomy].
    Sasano S; Kei J; Kaguraoka H; Iida H; Yoh T; Nitta S
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Jun; 41(6):1105-9. PubMed ID: 8336043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.